NxThera
Maple Grove
About NxThera
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company's technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life. BPH afflicts more than 32 million men in the United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $123.5M
- Funding stage: M&A
- Last round: Debt Financing (Jul 2017)
- Website: nxthera.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nxthera-107417 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.